Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Outlook Therapeutics Inc. (OTLK)

  • Technical Exchange News
  • Feb. 25, 2026, 19:05 UTC
  • 3
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 25, 2026, 19:04 UTC
  • 4
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Rallybio Corporation (RLYB)

  • Technical Exchange News
  • Feb. 25, 2026, 02:42 UTC
  • 10
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mereo BioPharma (MREO)

  • Technical Exchange News
  • Feb. 25, 2026, 02:41 UTC
  • 11
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Rallybio Corporation (RLYB)

  • Technical Exchange News
  • Feb. 24, 2026, 19:31 UTC
  • 9
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mereo BioPharma (MREO)

  • Technical Exchange News
  • Feb. 24, 2026, 19:31 UTC
  • 6
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ENLIVEX (ENLV)

  • Technical Exchange News
  • Feb. 24, 2026, 08:09 UTC
  • 9
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Enlivex Therapeutics Ltd. - Ordinary Shares. New value: Enlivex Ltd. - Ordinary Shares.

Comment Full text

Envoy Medical Inc (COCHW)

  • Technical Exchange News
  • Feb. 24, 2026, 03:01 UTC
  • 10
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adial Pharmaceuticals Inc (ADIL)

  • Technical Exchange News
  • Feb. 24, 2026, 03:01 UTC
  • 9
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ENLIVEX (ENLV)

  • Technical Exchange News
  • Feb. 24, 2026, 00:50 UTC
  • 8
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Enlivex Therapeutics Ltd. - Ordinary Shares. New value: Enlivex Ltd. - Ordinary Shares.

Comment Full text
  • Previous
  • 23
  • 24
  • 25
  • 26
  • 27
  • Next

Search

News categories

  • Technical Exchange News(11221)
  • Event(2606)
  • SEC News(198255)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(130822)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin